Associate Professor and consultant in medical oncology at the University of Genova – IRCCS Policlinico San Martino Hospital in Genova. Member of the guideline group on fertility preservation in cancer patients for ESMO, the European Society of Human Reproduction and Embryology and the Italian Association of Medical Oncology.

Prof. Matteo Lambertini has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Roche, Lilly, Novartis, AstraZeneca, Pfizer, Gilead, MSD, Pierre Fabre, Menarini, Nordic Pharma, Bayer, Ipsen, Daiichi Sankyo, Takeda, Sandoz, Libbs, JCO Consultant Editor, Chair of the ESO Certificate of Competence in Breast Cancer.

Non-financial interests: Member of the executive board of the BIG; Board member of the ISFP; ASCO Annual Meeting Scientific Program Committee on the Breast Cancer – Local/Regional/ Adjuvant Track